Various combination of protease inhibitors, oseltamivir, favipiravir, and chloroquin for treatment of covid19: a randomized control trial  Drug: oral  Thailand, coronavirus infections COVID19  80, all, 16–100  Treatment  Experimental: oseltamivir plus chloroquin in mild COVID19